Pritzker Molecular Engineering researchers led by Prof. Jeffrey Hubbell showed that their compound can eliminate the autoimmune reaction associated with multiple sclerosis in a laboratory setting.
  • blindsight@beehaw.org
    3·
    1 year ago

    Does anyone know a reasonable timeline, assuming everything works out (big if, I know) between something like this starting Phase I trials and widespread availability?

    Are we talking a few years, or like a decade?

    • Hirom@beehaw.org
      2·
      1 year ago

      I guess it would be more difficult to get approval than the average treatment if it’s the first of its kind.

      Also I’m not an expert in the field, and there are probably many factors that makes speculation difficult, such as funding, and does-it-work-in-humans, and funding.

  • Hirom@beehaw.org
    3·
    1 year ago

    Crossing fingers, hoping that clinical trials get funding and are successful.

    That’s be life changing for many people.

  • emma@beehaw.orgEnglish
    2·
    1 year ago

    This one actually sounds credible. Or maybe I’m just hoping too hard for a friend.